peptideTesamorelin
peptide

Tesamorelin.

4.8
Reviewed by Pierson Riley — Founder, UtritionReviewed under Utrition’s editorial methodologyLast reviewed Oct 2026Allergen-free

FDA-approved GHRH analog for HIV lipodystrophy.

peptideprescriptionfda-approvedgrowth-hormone
Evidence
A
Strong evidence
Best time
Evening
Prescription; follow medical guidance
Typical dose
Primary use
Peptide
Quick answer

Tesamorelin in one minute. FDA-approved GHRH analog for HIV lipodystrophy. Take in the evening. FDA approved only for specific indication.

What is Tesamorelin?

Tesamorelin (Egrifta) is FDA approved specifically for reducing excess abdominal fat in HIV patients with lipodystrophy. It is a prescription medication, not a general anti-aging or fat loss treatment.

Visceral fat reduction in HIV lipodystrophy patients

Keep reading

What is Tesamorelin?

FDA-approved GHRH analog for HIV lipodystrophy.

Tesamorelin (Egrifta) is FDA approved specifically for reducing excess abdominal fat in HIV patients with lipodystrophy. It is a prescription medication, not a general anti-aging or fat loss treatment.

What the evidence says

The overall evidence grade for Tesamorelin is A (strong — consistent, high-quality human evidence (systematic reviews, well-powered RCTs)). FDA approved for specific indication (HIV lipodystrophy).

Specific findings with supporting evidence:

Best-supported outcomes:

Where marketing outpaces evidence:

Dose and timing

Take it in the evening. Prescription; follow medical guidance.

Who it's for, and who should skip it

Most relevant for:

Not appropriate for:

Safety and cautions

Important: Prescription required. FDA approved only for specific indication. Caution: Off-label use. Using for general fat loss is off-label.

Common mistakes

Myths vs reality

A common misconception: Tesamorelin is approved for weight loss. In reality, only approved for HIV lipodystrophy.

How it interacts with other compounds

Questions people ask

Can I get tesamorelin for weight loss? It is only FDA approved for HIV lipodystrophy. Off-label use requires medical evaluation.

Editorial note

This guide summarizes the published evidence on Tesamorelin. It is educational content, not medical advice. Confirm with your clinician if you take prescription medications or manage a chronic condition.